YDES Financial Statements From 2010 to 2026
| YDES Stock | 11.82 0.52 4.21% |
Check YD Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among YD Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . YDES financial statements analysis is a perfect complement when working with YD Bio Valuation or Volatility modules.
Check out the analysis of YD Bio Correlation against competitors. YD Bio Company Number Of Employees Analysis
YD Bio's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current YD Bio Number Of Employees | 2 |
Most of YD Bio's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, YD Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, YD Bio is currently employing 2.0 people. This is 99.98% lower than that of the Healthcare sector and 99.63% lower than that of the Biotechnology industry. The number of employees for all United States stocks is 99.99% higher than that of the company.
YD Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining YD Bio's current stock value. Our valuation model uses many indicators to compare YD Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across YD Bio competition to find correlations between indicators driving YD Bio's intrinsic value. More Info.YD Bio is rated first in revenue category among its peers. It is rated first in ebitda category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value YD Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About YD Bio Financial Statements
YD Bio shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although YD Bio investors may analyze each financial statement separately, they are all interrelated. The changes in YD Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on YD Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for YDES Stock Analysis
When running YD Bio's price analysis, check to measure YD Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy YD Bio is operating at the current time. Most of YD Bio's value examination focuses on studying past and present price action to predict the probability of YD Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move YD Bio's price. Additionally, you may evaluate how the addition of YD Bio to your portfolios can decrease your overall portfolio volatility.